Biosimilar Newsletter Archive

11. 10.22.19 -- Addressing The Challenges Of Next-Generation Biotherapeutics
    10/22/2019
    10/22/19 Biosimilar Development Newsletter
12. 10.17.19 -- Comparative Biosimilar Trials: More Questions Than Answers?
    10/17/2019
    10/17/19 Biosimilar Development Newsletter
13. 10.15.19 -- Scale-Up Strategies For Retroviruses, Mabs, And More
    10/15/2019
    10/15/19 Biosimilar Development Newsletter
14. 10.10.19 -- FDA's Woodcock: Biosimilar Development Promotes Better Biologics
    10/10/2019
    10/10/19 Biosimilar Development Newsletter
15. 10.08.19 -- Top Five Topics To Consider As You Advance Through Therapeutic Milestones
    10/8/2019
    10/08/19 Biosimilar Development Newsletter
16. 10.03.19 -- How This Initiative Improved Biosimilar Infliximab Uptake
    10/3/2019
    10/03/19 Biosimilar Development Newsletter
17. 09.26.19 -- Why This Biosimilar Initiative Is One To Watch
    9/26/2019
    09/26/19 Biosimilar Development Newsletter
18. 09.24.19 -- 5 Ways To Optimize Biomanufacturing Process Efficiency Now
    9/24/2019
    09/24/19 Biosimilar Development Newsletter
19. 09.19.19 -- What These 2 Policies Mean For Biosimilars
    9/19/2019
    09/19/19 Biosimilar Development Newsletter
20. 09.12.19 -- Is It Time To Change The Biosimilar Regulatory Paradigm?
    9/12/2019
    09/12/19 Biosimilar Development Newsletter